Cargando…
A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565984/ https://www.ncbi.nlm.nih.gov/pubmed/28845272 http://dx.doi.org/10.1093/ve/vew036.022 |
| _version_ | 1783258466034384896 |
|---|---|
| author | James, Onyemata E. Johanna, Ledwaba Rawlings, Datir Babajehson, M. Ashrad, Ismail Anne, Derache Abimiku, Alash’le Dakum, Patrick Gillian, Hunt Ndembi, Nicaise |
| author_facet | James, Onyemata E. Johanna, Ledwaba Rawlings, Datir Babajehson, M. Ashrad, Ismail Anne, Derache Abimiku, Alash’le Dakum, Patrick Gillian, Hunt Ndembi, Nicaise |
| author_sort | James, Onyemata E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5565984 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55659842017-08-25 A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria James, Onyemata E. Johanna, Ledwaba Rawlings, Datir Babajehson, M. Ashrad, Ismail Anne, Derache Abimiku, Alash’le Dakum, Patrick Gillian, Hunt Ndembi, Nicaise Virus Evol Abstract Overview Oxford University Press 2017-03-05 /pmc/articles/PMC5565984/ /pubmed/28845272 http://dx.doi.org/10.1093/ve/vew036.022 Text en © Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access publication distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Abstract Overview James, Onyemata E. Johanna, Ledwaba Rawlings, Datir Babajehson, M. Ashrad, Ismail Anne, Derache Abimiku, Alash’le Dakum, Patrick Gillian, Hunt Ndembi, Nicaise A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria |
| title | A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria |
| title_full | A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria |
| title_fullStr | A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria |
| title_full_unstemmed | A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria |
| title_short | A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria |
| title_sort | a23 identification of hiv drug resistance mutation patterns using illumina miseq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in nigeria |
| topic | Abstract Overview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565984/ https://www.ncbi.nlm.nih.gov/pubmed/28845272 http://dx.doi.org/10.1093/ve/vew036.022 |
| work_keys_str_mv | AT jamesonyematae a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT johannaledwaba a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT rawlingsdatir a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT babajehsonm a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT ashradismail a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT annederache a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT abimikualashle a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT dakumpatrick a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT gillianhunt a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria AT ndembinicaise a23identificationofhivdrugresistancemutationpatternsusingilluminamiseqnextgenerationsequencinginpatientsfailingsecondlineboostedproteaseinhibitortherapyinnigeria |